Parkwalk

Parkwalk invests in innovative UK technology companies. Parkwalk also manage seed funds with Cambridge, Oxford & Bristol Universities & Imperial College.

[IP Group - visionary ventures @IPGroupplc]

Access that sets the platform apart 🔬

From one relationship to an ecosystem spanning capital, talent and institutions.

Over 25 years, IP Group, together with @ParkwalkAdvisor, has built deep partnerships with leading research institutions, including the University of Oxford, the University of Cambridge and Imperial College London, providing access to a pipeline of world-class science and innovation.

These relationships sit at the heart of a broader network. We also work alongside regional and university partners such as Northern Gritstone, where we manage the Northern Universities Venture Fund 🤝

Our model also extends internationally 🌏

In Australia, we partner with the Group of Eight and the University of Auckland, helping connect outstanding research with the capital and expertise needed to scale.

Together, this creates a differentiated platform that combines access, expertise and capital to identify, build and scale breakthrough innovation from some of the world’s leading institutions ⚡

From one relationship to a global innovation ecosystem.

And still building 🚀
#IPGroup #Innovation #DeepTech #Science #UniversityInnovation #VentureCapital #25Years

[Parkwalk @Parkwalk_VC]

Moa Technology, a spinout from the University of Oxford, raises £22.2m Series C funding round.

Read the release here: https://t.co/aW42QJuhhx

[IP Group - visionary ventures @IPGroupplc]

25 years of backing science that matters 🔬

25 years. 600+ companies. 15,000+ jobs. 📊

A proven model - combining long‑term balance sheet investment with third‑party capital - helping turn frontier science into global businesses.

1️⃣ 600+ companies backed
Across healthtech ❤️, deeptech 💡 and cleantech 🌍.
2️⃣ 15,000+ jobs created 👥
Through the companies IP Group has helped build and scale.
3️⃣ £1.69bn invested 💷
Patient capital deployed into science‑ and IP‑led innovation.
4️⃣ £1.5bn assets under management* 📈
Across IP Group and @ParkwalkAdvisor, including third‑party capital.
5️⃣ 4 unicorns created 🦄
Including @nanopore, @HingeHealth , Ceres Power and @FeaturespaceLtd.

Behind every statistic is a founder, researcher, colleague and breakthrough helping create real-world impact.

25 years in — and still building 🚀

* Includes third‑party capital; NAV + third‑party AUM as at 31 Dec 2025

[Parkwalk @Parkwalk_VC]

Meet Marley Health, a company bringing the power of AI and data-driven healthcare to veterinary medicine. 🐾

Watch the full video here: https://t.co/SCvG1TgqlC

[IP Group - visionary ventures @IPGroupplc]

🚀 We're delighted to be leading Mach42's £7m funding round alongside existing investors BGF and Foresight Group.

As semiconductor designs become increasingly complex, engineering teams need new tools to accelerate development while maintaining the highest levels of accuracy. Mach42 is tackling one of the industry's key challenges – analog circuit verification – with AI-driven technology that can dramatically improve simulation speed and coverage. ⚡️

By enabling engineers to verify complex analog circuits with up to 100x greater coverage, Mach42's technology has the potential to reduce development cycles, lower computational costs and accelerate time to market. As agentic approaches to chip design continue to emerge, the need for faster, physics-accurate simulation is only set to grow. 🤖🔬

This investment is a great example of the IP Group model in action, building on @ParkwalkAdvisor's early backing of the company and supporting its next stage of growth with follow-on capital from IP Group. We're excited to support the team as they scale commercial adoption and bring their world-leading technology to engineering teams worldwide. 🌍

Congratulations to Tim Haynes, Paul Neil and the wider Mach42 team on this important milestone. 👏

📖 Read more in the comments below 👇

#DeepTech #Semiconductors #AI #MachineLearning #AgenticAI #ChipDesign #EDA #Innovation #VentureCapital #IPGroup #ParkwalkAdvisors

[Parkwalk @Parkwalk_VC]

Meet @Brainomix, an Oxford University spinout using artificial intelligence to improve diagnosis and treatment decisions in stroke and lung disease.

Find out more here: https://t.co/qiZLgWwaQ1

[Parkwalk @Parkwalk_VC]

Parkwalk is pleased to announce its investment in Xen Quantum, a new venture developing chip-based hardware for Quantum Key Distribution (QKD), a technology designed to help secure data against future threats from quantum computing.

Read more here: https://t.co/7skE66026L

[Parkwalk @Parkwalk_VC]

Meet @Paragraf_Gr , the University of Cambridge spinout pioneering the commercial production of graphene-based electronic devices.

Watch the full video here: https://t.co/GMV0rGm9vO

[Parkwalk @Parkwalk_VC]

🔊 Pixel-Flo seed funding round announcement 🔊

Parkwalk has completed a new investment in Pixel-Flo, a Unviersity of Sheffield spinout, as part of the company's oversubscribed £5.25 million seed funding round.

Full release here: https://t.co/6osm3OY1Nz

[Parkwalk @Parkwalk_VC]

@Brainomix - enabling precision medicine for better treatment decisions. 🧠

Meet Brainomix, the University of Oxford spinout using artificial intelligence to help clinicians make faster, more informed treatment decisions.

Watch full video here: https://t.co/qiZLgWwaQ1

[Paragraf® @Paragraf_Gr]

Great to be part of the Parkwalk Portfolio Showcase last week.

Simon Thomas, John Burley, Andrey Nikolaenko and Forat El-Sayed represented Paragraf, presenting our #graphene‑based multiplexed ion‑sensing demo to the wider investor and innovation community, and sharing progress towards scalable, high‑performance sensing solutions.

It was a strong display of #UKinnovation, with an impressive range of university spinouts turning advanced research into commercial impact.

Thanks to the @ParkwalkAdvisor team for hosting such a well‑organised and engaging evening.

[Parkwalk @Parkwalk_VC]

Quantum Motion raises $160m Series C funding round. 🚀

Find out more here: https://t.co/kEERBoLbL9

[Parkwalk @Parkwalk_VC]

Densix, an Oxford University spinouts, raises $4m Seed funding round.

Read the release here: https://t.co/XFxUfxvBfr

[Parkwalk @Parkwalk_VC]

We are pleased to announce our latest investment in @GripAble_Rehab, an @imperialcollege spinout.

Read the release here: https://t.co/pKTcXxiXES

[IP Group - visionary ventures @IPGroupplc]

⚛️ To mark #WorldQuantumDay, we’re spotlighting 3 portfolio companies across @IPGroupplc & our EIS fund management business, @ParkwalkAdvisor, that are pushing the boundaries of what’s possible:

🔹 @quantum_motion - Developing silicon-based quantum computing technology designed to scale using established semiconductor manufacturing.

🔹 @OQC_Tech - Building superconducting quantum computers with a focus on robustness & real‑world commercial applications.

🔹 @PhasecraftLtd - Developing high-efficiency algorithms to make quantum computing practical for real-world applications sooner.

[Parkwalk @Parkwalk_VC]

We are pleased to announce our investment in K3 Metrology, a spinout from the National Physical Laboratory, who has raised a £2.75m Seed funding round.

Read more here: https://t.co/O1xDZoFTtF

[Parkwalk @Parkwalk_VC]

The scale-up shift: What's happening with #EIS?

Moray Wright features in @FTAdviser https://t.co/Qo5hOcVfoN

[Tax-Efficient Investment Magazine @TEIMagazine]

Backing university spinouts in an ever-evolving landscape

@ParkwalkAdvisor 's CEO Moray Wright discussed Parkwalk’s focus on university spinouts, along with outlining how their investment strategy fits in the EIS market.

Read more: https://t.co/xJUI3F5PAy

[IP Group - visionary ventures @IPGroupplc]

📊 2025 results out

📈 NAV per share up 13% to 110.4p;

💡 Opportunity for significant potential future royalty income as Group benefits from financial exposure to Pfizer’s obesity drug franchise;

💷 Confirmed target of delivering more than £250m of exits between 2025 and the end of 2027, having raised £68m in the year from exits.

https://t.co/ouRu6hzF40

#visionaryventures

[Parkwalk @Parkwalk_VC]

UK Research and Innovation’s latest review shines a useful light on the UK’s innovation landscape – both the momentum building across our universities and the structural gaps that still hold back scale.

Read the report here: https://t.co/jcoxdoQGTl @UKRI_News